After Discontinuation of Treatment with QRX003 Complete Reversal of Positive Clinical Improvements Across all Measured ...

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

Quoin Pharmaceuticals, a biotech company with a keen focus on rare diseases, has recently been making waves in the world of dermatology with its treatment for Netherton Syndrome. This rare genetic ...

Jan. 14, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan ...

We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient ...

Hepion Pharmaceuticals has had a turbulent year so far. With a YTD performance of -68.60%, its stock has struggled to gain traction in the market. This starkly contrasts with the broader market, as ...

IGC Pharma, Inc (NYSE American:IGC) (”IGC” or the “Company”), today announced that CEO Ram Mukunda and CCO Claudia Grimaldi ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Agios Pharma submitted a sNDA to the FDA after two Phase III trials studying PYRUKYND (mitapivat) in thalassemia met their ...